Vancouver, British Columbia--(Newsfile Corp. - February 12, 2026) - ExGen Resources Inc. (TSXV: EXG) (OTC Pink: BXXRF) ("ExGen" or the "Company") provides an update regarding Phoenix Copper Limited ("Phoenix"), the operator of the Empire copper project in Idaho, in which ExGen holds a 20% carried interest. In addition, ExGen owns 1,330,000 common shares of Phoenix.Phoenix announced on February 9 the suspension of the Executive Chairman and the Chief Financial Officer. (https://polaris.brighterir.com/public ...

Core Viewpoint - New Zealand Energy Corp. has successfully completed a non-brokered private placement, raising C$3,500,000 through the issuance of 17,500,000 common shares at a price of C$0.20 per share [1]. Group 1: Offering Details - The private placement was conducted under National Instrument 45-106 and was available to Canadian residents as well as certain jurisdictions outside Canada, including the United States and the United Kingdom [2]. - The net proceeds from the offering will be utilized to advance the company's gas storage business and for general corporate purposes [3]. - Advisory fees of C$29,250 were paid in cash to certain arm's length parties in connection with the offering [3]. Group 2: Insider Participation - Insiders Toby Pierce and Robert Bose participated in the offering, purchasing 800,000 and 1,800,000 common shares, respectively, for a total subscription amount of C$535,000 [4]. - This offering is classified as a "related party transaction" under Multilateral Instrument 61-101, but the company is exempt from obtaining a formal valuation and minority shareholder approval as the insiders' participation does not exceed 25% of the company's market capitalization [4]. Group 3: Company Overview - New Zealand Energy Corp. is a publicly listed energy company focused on developing oil, gas, and gas-storage opportunities in New Zealand [5]. - The company holds interests in multiple heritage assets and development-stage projects, including the Tariki Gas Storage Project in the Taranaki Basin [5]. - With a 50% ownership stake in the Waihapa production station, the company is positioned to quickly tie in near-term production and sell directly to the market [5].

Core Viewpoint - Petrus Resources Ltd. has announced a definitive agreement to acquire oil-weighted Cardium light oil assets in Alberta for approximately $33.4 million, which is expected to enhance its production and financial flexibility [1][4][7]. Transaction Details - The acquisition will be funded through a new Term Facility and net proceeds from a private placement, with an effective date of February 1, 2026, and expected closing around February 19, 2026, pending regulatory approvals [4][5][12]. - The total consideration for the acquisition is approximately $33.4 million, with customary adjustments and the assumption of certain obligations from the vendor [1][4]. Acquisition Highlights - The transaction is expected to increase Petrus' production by approximately 2,000 boe/d, with a liquids weighting increase to about 40%, representing an 11% rise [7][8]. - The acquisition metrics indicate a compelling pricing structure, with a multiple of operating income at 2.0x and a purchase price equal to approximately 51% of PDP NPV-10 [7][8]. - The acquired assets include long-life producing reserves and future drilling inventory, with proved developed producing reserves estimated at 5.8 MMboe, reflecting a 33% increase relative to Petrus' existing reserves [7][8]. Strategic Rationale - The acquisition aligns with Petrus' strategy of developing and producing oil and gas profitably in the Deep Basin, enhancing its operational flexibility and sustainability of cash flow generation [9][10]. - The added production base is expected to support a more consistent development program, improving capital efficiency and shareholder value [10][11]. Financial Structure - The Term Facility has been amended to include a non-revolving term facility of up to $35 million, specifically for funding the purchase price, with an interest rate of Canadian Prime Rate plus 3.75% [12][13]. - The company plans to use the net proceeds from the private placement to reduce the amount drawn under the Term Facility [12][18]. Offering Details - Petrus has entered into a bought deal agreement for a $6 million brokered private placement and a $4 million non-brokered private placement, with shares priced at C$1.75 each [2][14][15]. - The offering is expected to close around February 19, 2026, subject to conditions including approval by the Toronto Stock Exchange [19]. Reserves and Production Metrics - The acquisition includes significant reserves, with proved plus probable reserves totaling 32.6 MMboe and net developed acres of 44,532 [8][9]. - The transaction is projected to be accretive on a per-share basis, enhancing production and cash flow metrics for the company [11].

Core Viewpoint - Showcase Minerals Inc. has entered into an option agreement to acquire a significant silver property in British Columbia, which includes three mineral claims covering 2080.8 hectares and the former Comstock mine [1][4]. Property Acquisition - The property acquisition allows the company to earn a 100% interest, subject to a 3% net smelter returns royalty, through cash payments of $300,000 over two years and issuing shares valued at $100,000 on each anniversary of the agreement [4]. Historical Context - The Comstock mine has a historical production record from 1898 to 1920, with a total of 455 tonnes of ore mined, yielding 1,687,774 grams of silver, 12,387 grams of gold, 217,634 kilograms of lead, and 126,657 kilograms of zinc [2]. Geological Features - The mineralization at the Comstock mine is characterized by quartz veins within a brecciated zone, containing galena, sphalerite, minor tetrahedrite, and trace pyrargyrite [3]. Grassy Gold Project - The company is planning a spring drill program for the Grassy Gold Project, located near the Premier Gold Mine, which historically produced over two million ounces of gold [5]. Mineralization Details - The Grassy property features epithermal, low sulphidation mineralization, primarily consisting of pyrite, sphalerite, galena, and chalcopyrite within quartz-carbonate breccia veins [6]. Geochemical Program Results - In the 2024 geochemical program, the Rama Vein samples showed gold values between 12.68 to 31.9 ppm, silver values from 376 to 1,812 ppm, lead values from 0.3% to 39.89%, and zinc values from 0.68% to 26.93% [8]. Private Placement Financing - The company plans to complete a non-brokered private placement of up to 8,000,000 units at $0.10 per unit, aiming for total gross proceeds of up to $800,000, with specific allocations for flow-through shares and general working capital [9][10]. Insider Participation - Insiders may participate in the private placement, with exemptions from formal valuation and minority shareholder approval requirements [11]. Company Overview - Showcase Minerals Inc. focuses on the exploration and acquisition of mineral properties, particularly in British Columbia's precious metal sectors, including the Golden Triangle and historic silver districts [14].

Core Viewpoint - Sharp Therapeutics Corp. is initiating a non-brokered private placement of unsecured convertible notes totaling up to US$3.0 million, with the aim of using the proceeds for general working capital purposes [1]. Group 1: Note Offering Details - The proposed Note Offering will consist of notes with a principal amount of US$1,000 each, convertible into common shares at a price of US$2.00 per share [2]. - Each note will bear an interest rate of 6.0% per annum, calculated as simple interest and payable in cash on the maturity date [3]. - The notes will convert into common shares if the company completes an equity financing of at least US$7,000,000 prior to the maturity date, with a 20-day notice to note holders [4]. Group 2: Participation and Commitments - STX Partners, LLC and other insiders have confirmed their intention to participate in the Note Offering [5]. - The company previously announced a common share offering at US$2.50 per share, expected to close in the first quarter of 2026, with proceeds also aimed at general working capital [6]. - STX, the largest shareholder, has committed to purchase at least 1,600,000 common shares, contingent upon raising at least US$6,000,000 from other investors [7]. Group 3: Regulatory and Offering Conditions - The offerings will be conducted as private placements under Canadian securities laws and may also be offered in the U.S. under applicable exemptions [9]. - All issued notes and common shares will be subject to a four-month hold period and require approval from the TSX Venture Exchange [10]. - The insider participation in the offerings is classified as a related-party transaction, exempt from formal valuation or minority shareholder approval due to the market capitalization criteria [8]. Group 4: Company Overview - Sharp Therapeutics is a preclinical-stage company focused on developing small-molecule therapeutics for genetic diseases, utilizing a discovery platform that combines high throughput screening technologies [11].

Core Viewpoint - Nations Royalty Corp. has successfully closed a private placement offering, raising gross proceeds of C$15,000,000 through the sale of 9,375,000 units at a price of C$1.60 per unit, including the full exercise of the over-allotment option [1] Group 1: Offering Details - The offering consisted of units, each comprising one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at C$2.25 until January 30, 2029 [1] - Red Cloud Securities Inc. and Canaccord Genuity Corp. acted as underwriters, receiving cash fees of C$873,600 and 546,000 non-transferable common share purchase warrants as compensation [2] Group 2: Regulatory Compliance - The units were issued to Canadian purchasers under the listed issuer financing exemption, making them immediately freely tradeable in accordance with Canadian securities legislation [3] - The closing of the offering is subject to final approval from the TSX Venture Exchange [4] Group 3: Company Vision and Mission - Nations Royalty aims to unite First Nations and Indigenous groups across Canada, inviting external investors to participate as shareholders, thereby combining royalties and income from resource projects [6] - The company focuses on economic reconciliation and capacity building for Indigenous Peoples in public companies and capital markets [6] Group 4: Properties and Benefits - Nations Royalty has established five annual benefit payment entitlements related to various properties in Canada, including the Brucejack gold mine and the KSM Copper-Gold-Silver-Molybdenum deposit [7]

Core Viewpoint - Lexicon Pharmaceuticals, Inc. has announced a public offering of 32 million shares at a price of $1.30 per share, aiming to raise approximately $41.6 million before expenses [1] Group 1: Public Offering Details - The public offering consists of 32,000,000 shares priced at $1.30 each, with expected gross proceeds of $41.6 million [1] - The offering is set to close on or about February 2, 2026, pending customary closing conditions [1] - Underwriters have a 30-day option to purchase an additional 4,800,000 shares at the public offering price [1] Group 2: Concurrent Private Placement - Lexicon will also conduct a concurrent private placement, selling 22,400,000 shares of common stock and 184,366 shares of Series B Convertible Preferred Stock for expected gross proceeds of approximately $41.1 million [2] - The Series B Convertible Preferred Stock will convert into 9,218,290 shares of common stock, with an additional option for the purchaser to buy more shares [2] - The private placement is also scheduled to close on or about February 2, 2026, and is not contingent on the public offering [3] Group 3: Use of Proceeds - The net proceeds from both the public offering and private placement will be used to fund ongoing research and development of drug candidates, as well as for working capital and general corporate purposes [4] Group 4: Regulatory Information - A shelf registration statement for the public offering was filed with the SEC and declared effective [5] - The securities offered in the private placement will not be registered under the Securities Act [3]

Core Viewpoint - Lexicon Pharmaceuticals, Inc. has initiated an underwritten public offering of its common stock, with plans to grant underwriters a 30-day option for additional shares, subject to market conditions [1][2] Group 1: Offering Details - The public offering will include shares of common stock with a par value of $0.001, and the actual size and terms of the offering are not guaranteed [1] - Jefferies and Piper Sandler are serving as joint book-running managers for the offering [2] - Concurrently, Lexicon plans to conduct a private placement of common stock to Invus, L.P., its largest stockholder, which will not be registered under the Securities Act [3] Group 2: Use of Proceeds - Lexicon intends to utilize the net proceeds from the offering primarily for the research and development of its drug candidates, as well as for working capital and general corporate purposes [4] Group 3: Regulatory Information - A shelf registration statement related to the offering was filed with the SEC on August 2, 2024, and was declared effective on August 15, 2024 [5]

Core Viewpoint - Altura Energy Corp. is initiating a non-brokered private placement offering of a minimum of 10,000,000 units at a price of $0.10 per unit, aiming for gross proceeds of at least $1,000,000 [1][4]. Group 1: Offering Details - Each unit will consist of one common share and one common share purchase warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.25 for up to sixty months [2]. - If the closing price of the common shares reaches or exceeds $0.75 for twenty consecutive trading days, the company may accelerate the expiry date of the warrants to 30 days after a news release [2]. - The offering will be conducted through private placement under applicable exemptions from prospectus requirements in Canada and other jurisdictions, including the United States [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for site maintenance, additional well recompletions, working capital, and general corporate purposes [4]. Group 3: Closing and Regulatory Aspects - The offering is expected to close around January 30, 2026, subject to necessary approvals, including from the TSX Venture Exchange [6]. - The securities issued will have a hold period of four months and one day from the closing date in accordance with applicable securities laws [6]. Group 4: Insider Participation - The company anticipates that insiders will subscribe for units, which is considered a related party transaction under Multilateral Instrument 61-101 [7]. - The company intends to rely on exemptions from formal valuation and minority shareholder approval requirements as the transaction is not expected to exceed 25% of the company's market capitalization [7]. Group 5: Company Overview - Altura Energy Corp. is an exploration and production company with interests in the Holbrook basin of Arizona [9].

Core Viewpoint - Lux Metals Corp. has increased the size of its private placement from 17,500,000 units to 20,000,000 units at a price of $0.20 per unit, aiming for total gross proceeds of up to $4,000,000 [1][2]. Group 1: Private Placement Details - Each unit will consist of one common share and one transferable share purchase warrant, with each warrant exercisable into one additional share for a period of two years at a price of $0.40 per share [2]. - The gross proceeds from the issuance of the units will be allocated for exploration costs and general working capital [2]. Group 2: Regulatory and Compliance Information - The company may pay finders' fees in cash and/or non-transferable warrants in connection with the placement, subject to TSXV policies and applicable securities laws [3]. - The company anticipates closing the placement as soon as practicable, pending necessary regulatory approvals, including TSXV approval [3]. - All securities issued under the placement will be subject to regulatory holds expiring four months and one day from the date of issue [3].